Skip to main content

Articles

Page 5 of 14

  2. The argument about funding criteria poses challenges for health decision-makers in all countries. This study aimed to investigate the public and decision-maker preferences for pharmaceutical subsidy decisions ...

    Authors: Gita Afsharmanesh, Farimah Rahimi, Leila Zarei, Farzad Peiravian and Gholamhossein Mehralian
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:74
    Content type: Research Published on:

  3. One in four people experience a mental health problem every year and improving mental health care is an international priority. In the course of their work, pharmacists frequently encounter people with mental ...

    Authors: H. C. Gorton, H. Macfarlane, R. Edwards, S. Farid, E. Garner, M. Mahroof, S. Rasul, D. Keating, H. Zaman, J. Scott, I. Maidment and J. Strawbridge
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:73
    Content type: Research Published on:

  4. Easy access to medicines provided by private medicine retailing facilities including that of over-the-counter medicine retailers, have gained prominence in sub-Saharan Africa. Although over-the-counter medicin...

    Authors: Benjamin Kwarteng Frempong, Anthony Amalba, Nina Donkor and Kwadwo Owusu Akuffo
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:72
    Content type: Research Published on:

  5. Job satisfaction of pharmacy professionals is appreciably related to quality of pharmaceutical care. Poor Job satisfaction is associated with low productivity, absenteeism, high turnover and reduced working ho...

    Authors: Muluwork Sahile Berassa, Tebeje Ashegu Chiro and Selamawit Fanta
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:71
    Content type: Research Published on:

  6. Challenges exist in developing work schedules for hospital pharmacy staff due to the need to meet around the clock patient care requirements. Work–life integration and reduced burnout are increasingly importan...

    Authors: Jessica Wright, Richard Arndt, Jason Christensen, Kirstin Kooda and Julie Cunningham
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:70
    Content type: Letter to the editor Published on:

  7. Inappropriate use of antimicrobials in both humans and animals is a key driver of antimicrobial resistance (AMR). In addition, human behaviours such as poor disposal of antimicrobials in the environment can in...

    Authors: David Musoke, Carol Namata, Grace Biyinzika Lubega, Freddy Eric Kitutu, Lawrence Mugisha, Saba Amir, Claire Brandish, Joviah Gonza, Deborah Ikhile, Filimin Niyongabo, Bee Yean Ng, Jean O’Driscoll, Kate Russell-Hobbs, Jody Winter and Linda Gibson
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:69
    Content type: Research Published on:

  8. The expansion of the pharmacist-led services has resulted in increased demand to have evidence in terms of necessity, efficacy, and cost. Evidence-based practice is crucial to provide the best patient health o...

    Authors: Daneh Obaid, Faris El-Dahiyat and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:68
    Content type: Commentary Published on:

  9. Globally, non-communicable diseases (NCDs) are recognised as a leading cause of morbidity and mortality. Medications and medicines optimisation play an important role in the management of modifiable physiologi...

    Authors: Mohamed Ahmed Syed, Ahmed Sameer Al Nuaimi, Hamda Abdulla A/Qotba, Abduljaleel Abdullatif Zainel, Tamara Marji and Uzma Razaq
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:67
    Content type: Short report Published on:

  10. Coronavirus disease (COVID-19) pandemic posed a critical threat to public health in the past year and has not been fully controlled so far. The nature of front-line young hospital pharmacists’ occupation puts ...

    Authors: Jiahao Wu, Jian Cai, Ming Fang, Yan Wang and Feng Xu
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:66
    Content type: Research Published on:

  12. These days, pharmaceutical customers are the utmost stakeholders in the healthcare supply chain, and ensuring their satisfaction with the logistics services has become worthwhile. This study aimed to investiga...

    Authors: Tafesse Gizaw, Mekonnen Bogale and Tadesse Gudeta
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:64
    Content type: Research Published on:

  13. Patients with cardiovascular diseases (CVD) are at high risk of experiencing drug–drug interactions (DDIs). The objective of this study was to evaluate the frequency, level and risk factors associated with pot...

    Authors: Zarka Akbar, Sundas Rehman, Asad Khan, Amjad Khan, Muhammad Atif and Nafees Ahmad
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:63
    Content type: Research Published on:

  14. Dispensing of antibiotics by over the counter medicine sellers (OTCMS) is a major driver of inappropriate use and resistance in low and middle income countries. Recent studies in Ghana revealed the need to con...

    Authors: Samuel Afari-Asiedu, Marlies Hulscher, Martha Ali Abdulai, Ellen Boamah-Kaali, Heiman F. L. Wertheim and Kwaku Poku Asante
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:62
    Content type: Research Published on:

  15. This commentary shares the experience of a hospital pharmacy department in providing healthcare services during the COVID-19 outbreak in Malaysia. During this pandemic, the medication delivery system is redesi...

    Authors: Kah Shuen Thong, Manimegahlai Selvaratanam, Chiew Ping Tan, Meng Fei Cheah, Hoey Lin Oh, Pooi Mun Lee, Chii-Chii Chew, Chee-Tao Chang and Jason Choong Yin Lee
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:61
    Content type: Commentary Published on:

  17. Deciding on pharmaceutical subsidy is regarded as a challenging issue for healthcare policymakers in Iran in most times. Public preferences, rarely attended in Iran, could be invaluable for including a particu...

    Authors: Mansoor Delpasand, Alireza Olyaaeemanesh, Ebrahim Jaafaripooyan, Akbar Abdollahiasl, Majid Davari and Ali Kazemi Karyani
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:59
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2021 14:75

  18. Pharmaceutical’s procurement is a core component of logistics management, and has a significant influence on product availability, and total supply chain costs. In Ethiopia, there are few studies on this topic...

    Authors: Gotuma Negera, Hailu Merga and Tadesse Gudeta
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:58
    Content type: Research Published on:

  19. Access to essential medicines is a universal human right and availability and affordability are the preconditions for it. In line with the sustainable development goals, World Health Organization (WHO) has out...

    Authors: Mekonnen Sisay, Firehiwot Amare, Bisrat Hagos and Dumessa Edessa
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:57
    Content type: Research Published on:

  20. Given the impact of politico-economic sanctions on the pharmaceutical supply chain, this study aims to identify practical strategies to improve the resilience of the Iranian supply chain in pharmaceutical proc...

    Authors: Peivand Bastani, Zahra Dehghan, Seyyed Mansoor Kashfi, Hesam Dorosti, Mohammadtaghi Mohammadpour, Gholamhossein Mehralian and Ramin Ravangard
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:56
    Content type: Research Published on:

  21. Medication adherence is an important concept particularly among the elderly that can, directly and indirectly, affect the health system’s costs and the elderly’s health, quality of life, and functional abiliti...

    Authors: Peivand Bastani, Parisa Bikineh, Gholamhossein Mehralian, Omid Sadeghkhani, Rita Rezaee, Zahra Kavosi and Ramin Ravangard
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:55
    Content type: Research Published on:

  23. With the approval of biosimilars for subcutaneously administered products, such as adalimumab, etanercept and insulin, biosimilars become increasingly available in ambulatory care. Little is known about the kn...

    Authors: Liese Barbier, Yannick Vandenplas, Steven Simoens, Paul Declerck, Arnold G. Vulto and Isabelle Huys
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:53
    Content type: Research Published on:

  24. A multi-criteria decision analysis (MCDA) approach has been suggested for helping purchasers in low- and middle-income countries in an evidence-based assessment of multi-source pharmaceuticals to mitigate pote...

    Authors: Anke-Peggy Holtorf, Erna Kristin, Anunchai Assamawakin, Nilawan Upakdee, Rina Indrianti and Napassorn Apinchonbancha
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:52
    Content type: Research Published on:

  25. Lebanon, a developing Middle Eastern country, was hit by the COVID-19 pandemic that occurred amid a severe national economic crisis. Community pharmacists are responsible for dispensing appropriate medications...

    Authors: Rony M. Zeenny, Ahmad Dimassi, Hala Sacre, Ghada El Khoury, Aline Hajj, Rita Farah, Hind Hajj, Nathalie Lahoud, Marwan Akel, Souheil Hallit and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:51
    Content type: Research Published on:

  26. People living with diabetes are more vulnerable to drug-related problems due to the presence of multiple diseases. This study aimed to identify drug-related problems and contributing factors among diabetic pat...

    Authors: Tadesse Sheleme, Tamiru Sahilu and Desalegn Feyissa
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:50
    Content type: Research Published on:

  27. Globally, self-medication is a common practice, and an increasingly perceived necessity to relieve burdens on health services. However, inappropriate self-medication may result to reduced health outcomes, incr...

    Authors: Wuraola Akande-Sholabi, Amen. T. Ajamu and Rasaq Adisa
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:49
    Content type: Research Published on:

  29. Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die ...

    Authors: Temitope Ben-Ajepe, Ifechukwu Benedict Nwogu, Damilola Quazeem Olaoye, Abdulhafeez Ayodele Mustapha, Theogene Uwizeyimana and Yusuff Adebayo Adebisi
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:47
    Content type: Commentary Published on:

  31. This research aimed to evaluate analgesic utilization in public hospitals from 2013 to 2018 by analyzing the procurement data of 793 hospitals in China.

    Authors: Honghao Shi, Xianwen Chen, Xueli Liu, He Zhu, Fei Yu, Carolina Oi Lam Ung, Wai Sin Chan, Hao Hu and Sheng Han
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:45
    Content type: Research Published on:

  32. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Ammar Abdulrahman Jairoun, Sabaa Saleh Al‑Hemyari, Naseem Mohammed Abdulla, Faris El‑Dahiyat, Maimona Jairoun, Saleh Karamah AL‑Tamimi and Zaheer‑Ud‑Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:44
    Content type: Correction Published on:

    The original article was published in Journal of Pharmaceutical Policy and Practice 2021 14:38

  33. Adequate quality systems throughout pharmaceutical supply chains are crucial to protect individuals and communities from substandard and falsified medical products. Thus, pharmaceutical distributors are regula...

    Authors: Anthony Bourasseau, Laurine Lavergne and Raffaella Ravinetto
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:43
    Content type: Research Published on:

  34. Cardiovascular disease (CVD) is an emerging contributor to national morbidity and mortality in Saudi Arabia. CVD risk prevention services are limited, particularly with an over-utilised public health sector an...

    Authors: Hadi A. Almansour, Nouf M. Aloudah, Tariq M. Alhawassi, Betty Chaar, Ines Krass and Bandana Saini
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:42
    Content type: Research Published on:

  35. The implementation of pharmaceutical services in hospitals contributes to the appropriate use of medicines and patient safety. However, the relationship of implementation with the legal framework and organizat...

    Authors: Laura C. Vargas López, Fela Viso Gurovich, Anahí Dreser Mansilla, Veronika J. Wirtz and Michael R. Reich
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:41
    Content type: Research Published on:

  36. Over the last year, the dangerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly around the world. Malaysia has not been excluded from this COVID-19 pandemic. The resurgence of...

    Authors: Ching Siang Tan, Saim Lokman, Yao Rao, Szu Hua Kok and Long Chiau Ming
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:40
    Content type: Commentary Published on:

  37. Proper hand hygiene using alcohol-based handrub (ABHR) is an effective preventive approach for the current Coronavirus Disease 2019 (COVID-19) pandemic and other infections. World Health Organization recommend...

    Authors: Muluken Nigatu Selam, Regasa Bayisa, Andualem Ababu, Mahdi Abdella, Edessa Diriba, Minychel Wale and Assefa Mulu Baye
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:39
    Content type: Research Published on:

  38. Since the WHO announced that Covid-19 had become a global pandemic, online pharmacies have emerged as an extremely popular way to purchase medication due to the quarantine measures introduced by numerous count...

    Authors: Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Naseem Mohammed Abdulla, Faris El-Dahiyat, Maimona Jairoun, Saleh Karamah AL-Tamimi and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:38
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2021 14:44

  39. We considered the extent of the contribution of publicly funded research to the late-stage clinical development of pharmaceuticals and medicinal products, based on the European Commission (EC) FP7 research fun...

    Authors: L. Schmidt, O. Sehic and C. Wild
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:37
    Content type: Research Published on:

  40. Drug-related problems (DRPs) can occur at any stages of medication use processes, and a single drug could be associated with multiple DRPs. Once happened, it adversely affects health outcomes. In Ethiopia, eva...

    Authors: Fuad Adem, Jemal Abdela, Dumessa Edessa, Bisrat Hagos, Abraham Nigussie and Mohammed A. Mohammed
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:36
    Content type: Review Published on:

  41. Hyperglycemia is an undisputed epidemiological risk factor for microvascular complications in both type 1 and type 2 diabetes, integral in their causal pathways. Importantly, interventions that reduce the hype...

    Authors: Darren K. McGuire, Silvio E. Inzucchi, Odd Erik Johansen, Julio Rosenstock, Jyothis T. George and Nikolaus Marx
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:35
    Content type: Commentary Published on:

  42. In Nigeria, there is a prevalence of aversive life circumstances that frequently assail the mental health and well-being of the citizens, mitigating the impact of which necessitates the institution of psychoth...

    Authors: Adeboye Olakunle Bamgboye, Ibrahim Adebayo Hassan, Yusuff Adebayo Adebisi, Rachael Oluwatoyosi Farayola and Theogene Uwizeyimana
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:34
    Content type: Commentary Published on:

  45. Drug use evaluation is a structured, methodological, and criteria-based drug assessment system that helps to evaluate the actual trend of drug use in a particular setting. If drug prescription practices are in...

    Authors: Bereket Bahiru Tefera, Melese Getachew and Bekalu Kebede
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:31
    Content type: Review Published on:

  46. Advanced therapy medicinal products (ATMPs) represent an important cornerstone for innovation in healthcare. However, uncertainty on the value, the high average cost per patient and their one-shot nature has r...

    Authors: Virginia Ronco, Myriam Dilecce, Elena Lanati, Pier Luigi Canonico and Claudio Jommi
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:30
    Content type: Research Published on:

  47. Insufficient access to quality, safe, efficacious and affordable medical products in Africa has posed a significant challenge to public health for decades. In part, this is attributed to weak or absent policie...

    Authors: Bakani Mark Ncube, Admire Dube and Kim Ward
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:29
    Content type: Commentary Published on:

  48. Monitoring adverse drug reactions is a vital issue to ensure drug safety and to protect the general public from medication-related harmful effects. In order to properly monitor drug safety, a regulatory system...

    Authors: Zuzaan Zulzaga, Erdenetuya Myagmarsuren, Herman J. Woerdenbag and Eugene P. van Puijenbroek
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:15
    Content type: Commentary Published on:

  49. Measuring access to medicines has often been limited to assessing availability and affordability, while little is known regarding other dimensions of access including geographical accessibility. Our study aims...

    Authors: Cindrel Tharumia Jagadeesan and Veronika J. Wirtz
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:28
    Content type: Review Published on:

  50. Self-care is one of the growing tasks of community pharmacy professionals. They are highly engaged in consultations in response to specific drug request (product-based presentation) or symptoms clients describ...

    Authors: Dawit Wondimsigegn, Berhanemeskel Woldegerima and Asefa Adimasu Taddese
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:26
    Content type: Research Published on:
Submit manuscript

Follow

Annual Journal Metrics

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us